Average Co-Inventor Count = 11.17
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Exelixis, Inc. (14 from 175 patents)
2. Symphony Evolution, Inc. (4 from 10 patents)
3. Signal Pharmaceuticals, Inc. (3 from 169 patents)
4. Other (1 from 832,843 patents)
5. Axys Pharmaceuticals, Inc. (1 from 40 patents)
23 patents:
1. 11597699 - MEK inhibitors and methods of their use
2. 10266518 - Solid dosage formulations of substituted quinazoline receptor-type kinase modulators and methods of use thereof
3. 9796704 - Substituted quinazolines as receptor-type kinase inhibitors
4. 9359332 - Processes for the preparation of substituted quinazolines
5. 8697737 - Raf modulators and methods of use
6. 8658654 - Receptor-type kinase modulators and methods of use
7. 8648066 - Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture
8. 8637499 - Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture
9. 8372851 - Pyrazolo pyrimidines as casein kinase II (CK2) modulators
10. 8362002 - Azetidines as MEK inhibitors for the treatment of proliferative diseases
11. 8101625 - Pyrimidinones as Casein Kinase II (CK2) modulators
12. 8076338 - Kinase modulators and methods of use
13. 8012956 - Tropane compounds
14. 7915250 - Azetidines as MEK inhibitors for the treatment of proliferative diseases
15. 7872014 - Anaplastic lymphoma kinase modulators and methods of use